Julian C. van Capelleveen

Statistics

Publications

Citations

1.3K

H-Index

Active since

2013

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

University of Cambridge

University of California San Diego

Medical Research Council

Sanquin

Julian C. van Capelleveen is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, atherosclerosis, and cardiovascular disease.

Top concepts

MedicineAtherosclerosisGeneticsPathologyCardiovascular DiseaseEpidemiologyPharmacologyPublic HealthVascular BiologyMetabolic Syndrome

Publications per year

2013–2018

Publications

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

Nicholas J. Viney, Julian C. van Capelleveen, Richard S. Geary et al. · The Lancet · 2016 · 730 citations

Dose-ranging Trials, Pharmacology, Hyperlipidemia +7

Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease

Tom R. Webb, Jeanette Erdmann, Kathleen Stirrups et al. · Journal of the American College of Cardiology · 2017 · 261 citations · Full text

Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk

Julian C. van Capelleveen, Sophie J. Bernelot Moens, Xiaohong Yang et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2017 · 69 citations · Full text

ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol Levels

Laia Trigueros‐Motos, Julian C. van Capelleveen, Federico Torta et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2017 · 66 citations · Full text

Arterial and Cellular Inflammation in Patients with CKD

Sophie J. Bernelot Moens, Simone L. Verweij, Fleur M. van der Valk et al. · Journal of the American Society of Nephrology · 2016 · 58 citations · Full text

1–5 of 12